TCNNF Trulieve Cannabis Corp.

OTC Medicinal Chemicals & Botanical Products A1 CIK: 0001754195
AI RATING
HOLD
62% Confidence

Investment Thesis

Trulieve demonstrates paradoxical fundamentals: strong free cash flow generation ($228.6M, 19.4% FCF margin) and a fortress balance sheet with excellent liquidity (4.43x current ratio) and minimal leverage (0.12x Debt/Equity), but this is severely undermined by persistent net losses (-$116.4M, -9.9% margin), stagnant revenue (-0.4% YoY), and negative shareholder returns (ROE -10.2%, ROA -4.3%). The significant disconnect between positive operating cash flow and negative net income suggests material non-cash charges, acquisitions-related amortization, or accounting adjustments masking core profitability challenges.

Strengths

  • + Exceptional free cash flow generation of $228.6M with 19.4% FCF margin, demonstrating operational cash generation capability
  • + Fortress balance sheet with excellent liquidity metrics (4.43x current ratio, 2.52x quick ratio) and conservative leverage (0.12x Debt/Equity, 9.8x interest coverage)
  • + Healthy gross margins of 60.2% indicating pricing power and operational efficiency in core cannabis retail operations

Risks

  • ! Persistent net unprofitability (-$116.4M loss) with negative equity returns (ROE -10.2%, ROA -4.3%) destroying shareholder value despite positive cash flow
  • ! Stagnant revenue growth at -0.4% YoY with no evidence of organic expansion in maturing cannabis retail market
  • ! Material divergence between operating cash flow and net income suggests significant non-cash charges, write-downs, or acquisition-related amortization obscuring true profitability
  • ! Cannabis industry regulatory uncertainty with federal legal constraints and state-level variability creating structural business risks

Key Metrics to Watch

Financial Metrics

Revenue
1.2B
Net Income
-116.4M
EPS (Diluted)
$-0.58
Free Cash Flow
228.6M
Total Assets
2.7B
Cash
255.5M

Profitability Ratios

Gross Margin 60.2%
Operating Margin 12.1%
Net Margin -9.9%
ROE -10.2%
ROA -4.3%
FCF Margin 19.4%

Balance Sheet & Liquidity

Current Ratio
4.43x
Quick Ratio
2.52x
Debt/Equity
0.12x
Debt/Assets
57.6%
Interest Coverage
9.78x
Long-term Debt
136.7M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-04-17T05:33:29.745759 | Data as of: 2025-12-31 | Powered by Claude AI